NO152446C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-substituerte hypoxantinderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-substituerte hypoxantinderivater

Info

Publication number
NO152446C
NO152446C NO792791A NO792791A NO152446C NO 152446 C NO152446 C NO 152446C NO 792791 A NO792791 A NO 792791A NO 792791 A NO792791 A NO 792791A NO 152446 C NO152446 C NO 152446C
Authority
NO
Norway
Prior art keywords
hypoxantin
derivatives
substituted
preparation
therapeutic active
Prior art date
Application number
NO792791A
Other languages
English (en)
Norwegian (no)
Other versions
NO152446B (no
NO792791L (no
Inventor
Alfredo Giner-Sorolla
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of NO792791L publication Critical patent/NO792791L/no
Publication of NO152446B publication Critical patent/NO152446B/no
Publication of NO152446C publication Critical patent/NO152446C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Adhesives Or Adhesive Processes (AREA)
NO792791A 1978-09-15 1979-08-28 Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-substituerte hypoxantinderivater NO152446C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,804 US4221910A (en) 1978-09-15 1978-09-15 9-(Hydroxy alkyl)purines

Publications (3)

Publication Number Publication Date
NO792791L NO792791L (no) 1980-03-18
NO152446B NO152446B (no) 1985-06-24
NO152446C true NO152446C (no) 1985-10-02

Family

ID=25478624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792791A NO152446C (no) 1978-09-15 1979-08-28 Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-substituerte hypoxantinderivater

Country Status (26)

Country Link
US (1) US4221910A (ko)
EP (1) EP0009155B1 (ko)
JP (1) JPS5559188A (ko)
AT (1) ATE1814T1 (ko)
AU (1) AU527881B2 (ko)
CA (1) CA1121818A (ko)
CS (1) CS241023B2 (ko)
DD (1) DD146050A5 (ko)
DE (1) DE2964059D1 (ko)
DK (1) DK145627C (ko)
ES (1) ES484168A1 (ko)
FI (1) FI67847C (ko)
GR (1) GR72523B (ko)
HU (1) HU180892B (ko)
IE (1) IE48826B1 (ko)
IL (1) IL58086A (ko)
IN (1) IN153050B (ko)
MX (1) MX6270E (ko)
NO (1) NO152446C (ko)
NZ (1) NZ191482A (ko)
PH (1) PH15921A (ko)
PL (2) PL124177B1 (ko)
PT (1) PT70179A (ko)
RO (1) RO77559A (ko)
YU (1) YU41885B (ko)
ZA (1) ZA793972B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
JPS59135334A (ja) * 1983-01-24 1984-08-03 Kawasaki Steel Corp デジタル式張力測定装置
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
AU709454B2 (en) * 1994-07-25 1999-08-26 Alvin J. Glasky Carbon monoxide dependent guanylyl cyclase modifiers
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH443312A (fr) * 1963-10-29 1967-09-15 Ajinomoto Kk Procédé de préparation du 1-N-oxyde d'hypoxanthine et du 1-N-oxyde d'inosine substituée ou non, et utilisation des produits obtenus par ce procédé poutilisation des produits obtenus par ce procédé pour la préparation de la 2,6-dichloro-purine et 9-B-D-ribofuranosyl purine substitua ée ou non
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3813394A (en) * 1969-08-18 1974-05-28 Fujisawa Pharmaceutical Co Purine derivatives having hypocholesterolemic activity
JPS504012A (ko) * 1972-12-16 1975-01-16
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4031218A (en) * 1976-04-28 1977-06-21 Mallinckrodt, Inc. 7-(2,3-Dihydroxypropyl-1,3-di-n-propylxanthine and a pharmaceutical composition containing same useful as a bronchial muscle relaxant

Also Published As

Publication number Publication date
IE48826B1 (en) 1985-05-29
FI792848A (fi) 1980-03-16
US4221910A (en) 1980-09-09
DK145627C (da) 1983-06-20
AU5055679A (en) 1980-03-20
IN153050B (ko) 1984-05-26
CA1121818A (en) 1982-04-13
FI67847C (fi) 1985-06-10
DE2964059D1 (en) 1982-12-23
PH15921A (en) 1983-04-22
CS241023B2 (en) 1986-03-13
RO77559A (ro) 1982-02-01
JPS5559188A (en) 1980-05-02
PL124177B1 (en) 1982-12-31
EP0009155B1 (en) 1982-11-17
HU180892B (en) 1983-05-30
NZ191482A (en) 1984-04-27
YU224679A (en) 1984-06-30
MX6270E (es) 1985-02-27
JPH031310B2 (ko) 1991-01-10
DK145627B (da) 1983-01-03
ATE1814T1 (de) 1982-12-15
PL124228B1 (en) 1983-01-31
ZA793972B (en) 1980-09-24
IL58086A (en) 1982-04-30
AU527881B2 (en) 1983-03-31
ES484168A1 (es) 1980-09-01
NO152446B (no) 1985-06-24
FI67847B (fi) 1985-02-28
GR72523B (ko) 1984-11-16
YU41885B (en) 1988-02-29
IE791752L (en) 1980-03-15
PL218318A1 (ko) 1980-06-16
CS622779A2 (en) 1985-06-13
IL58086A0 (en) 1979-12-30
NO792791L (no) 1980-03-18
DD146050A5 (de) 1981-01-21
PT70179A (en) 1979-10-01
DK385579A (da) 1980-03-16
EP0009155A1 (en) 1980-04-02

Similar Documents

Publication Publication Date Title
NO152446C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-substituerte hypoxantinderivater
NO792829L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater
NO149888C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-substituerte-2`-hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
FR2416222A1 (fr) Derives perfluoroalkyl-thioethyl-ether
JPS5412372A (en) Thiazolidine derivative and its preparation
JPS5432460A (en) Cycloalkylidenemethylphenylacetic acid derivative and their preparation
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
NO167865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater.
NO810185L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracenon-derivater
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater
FR2422651A1 (fr) Derives de pyrrolidinecarboxaldehyde et de piperidinecarboxaldehyde a usage therapeutique
DE2960324D1 (en) 4,5-methano-bufadienolide-rhamnosides, process for their preparation and medicines containing them
IE43248L (en) Araliphatic dihalogen compounds.
JPS52100470A (en) Synthesis of hydantoin derivatives
JPS5432466A (en) Thiazolidine derivatives and their preparation
JPS527994A (en) Process for preparing novel pyrimido (4,5-d) pyrimidine derivatives
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
JPS5427564A (en) 1-branched alkylcarbonyl-3-(3,5-dihalogenophenyl) hydantoins, their preparation, and bactericides for pomicultural and horticultural uses containing the same as active agent.
JPS51148025A (en) Insecticides, miticides and their preparation
JPS5368800A (en) Cycloalkyl substd. pyrrolotriazolopyrimidine derivatives
JPS53124276A (en) Uracil derivatives
JPS5212197A (en) Preparation of benzimidazoisoquinoline derivatives
NO822221L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-3-alkynylamino-2-propanol-derivater
JPS5439069A (en) 2-methylfuran derivatives